For full functionality of this website it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser

Session Details

Working Towards Global Patient Access: Emerging Markets in Cell and Gene Therapy
Saturday, June 1, 2024 10:15 AM - 11:15 AM  
Room 208-209
Roundtable
Working Towards Global Patient Access: Emerging Markets in Cell and Gene Therapy

Moderator
  • Desiree Kosan, MS, RN, OCN, Johnson & Johnson Innovative Medicine, United States
Panelists
  • Camila Donadel, MD, Blood Center of Ribeirao Preto, Brazil
  • Flávia Mesquita Gava, MD, Blood Center of Ribeirao Preto, Brazil
  • Maroun Khoury, PhD, IMPACT - Center of Interventional Medicine for Precision and Advanced Cellular Therapy, Chile

Understand how CAR Ts are being implemented in emerging markets and debate whether novel therapeutic approaches such as allogeneic NK cells, in vivo gene editing, and combination therapies will enable broader patient access globally.

Key Learning Objectives

Implementing CAR-T Therapy in Developing Countries:

1. Gain insight into the unique challenges faced by developing countries in implementing CAR-T therapy, including limited infrastructure, high costs, and lack of trained personnel.
2. Explore the potential opportunities for enhancing accessibility to CAR-T therapy in developing countries, such as collaboration between stakeholders, technological innovations, and simplified manufacturing processes.
 

Desiree Kosan
CAR-T Cell Collections Operations Manager
Johnson & Johnson Innovative Medicine
Moderator


Camila Derminio Donadel Gonçalves
physician
Fundacao Hemocentro de Ribeirão Preto
Panelist


Maroun Khoury
Executive Director
IMPACT-Center of interventional medicine for precision and advanced cellular therapy
Panelist


Flavia Gava
Pediatric Hematologist
Blood Center of Ribeirao Preto
Panelist